Compile Data Set for Download or QSAR
Report error Found 13 Enz. Inhib. hit(s) for PDB: 5WHR
TargetIndoleamine 2,3-dioxygenase 1(Human)
Iteos Therapeutics

Curated by ChEMBL
LigandPNGBDBM310195(US9603836, Compound 2 | (-)-(R)-3-(5-fluoro-1H- in...)
Affinity DataKd:  6.00E+3nMAssay Description:Binding affinity to ferrous form of human recombinant IDO-1More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2020
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetIndoleamine 2,3-dioxygenase 1(Human)
Iteos Therapeutics

Curated by ChEMBL
LigandPNGBDBM310195(US9603836, Compound 2 | (-)-(R)-3-(5-fluoro-1H- in...)
Affinity DataKd:  150nMAssay Description:Binding affinity to ferric form of human recombinant IDO-1 in absence of oxygen and presence of tryptophanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2020
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetIndoleamine 2,3-dioxygenase 1(Human)
Iteos Therapeutics

Curated by ChEMBL
LigandPNGBDBM310195(US9603836, Compound 2 | (-)-(R)-3-(5-fluoro-1H- in...)
Affinity DataKd:  160nMAssay Description:Binding affinity to ferric form of human recombinant IDO-1 in absence of oxygenMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2020
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetIndoleamine 2,3-dioxygenase 1(Human)
Iteos Therapeutics

Curated by ChEMBL
LigandPNGBDBM310195(US9603836, Compound 2 | (-)-(R)-3-(5-fluoro-1H- in...)
Affinity DataKd:  7.00E+3nMAssay Description:Binding affinity to ferric form of human recombinant IDO-1More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2020
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetIndoleamine 2,3-dioxygenase 1(Human)
Iteos Therapeutics

Curated by ChEMBL
LigandPNGBDBM310195(US9603836, Compound 2 | (-)-(R)-3-(5-fluoro-1H- in...)
Affinity DataIC50: 120nMAssay Description:To measure enzymatic activity of human IDO1, the reaction mixture contained (final concentrations) potassium phosphate buffer (50 mM, pH 6.5), ascorb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2019
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetIndoleamine 2,3-dioxygenase 1(Human)
Iteos Therapeutics

Curated by ChEMBL
LigandPNGBDBM310195(US9603836, Compound 2 | (-)-(R)-3-(5-fluoro-1H- in...)
Affinity DataIC50: 120nMAssay Description:The compounds of the present invention inhibit the enzymatic activity of human IDO1.To measure enzymatic activity of human IDO1, the reaction mixture...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2020
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetIndoleamine 2,3-dioxygenase 1(Human)
Iteos Therapeutics

Curated by ChEMBL
LigandPNGBDBM310195(US9603836, Compound 2 | (-)-(R)-3-(5-fluoro-1H- in...)
Affinity DataIC50: 120nMAssay Description:To measure enzymatic activity of human IDO1, the reaction mixture contained (final concentrations) potassium phosphate buffer (50 mM, pH 6.5), ascorb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetIndoleamine 2,3-dioxygenase 1(Human)
Iteos Therapeutics

Curated by ChEMBL
LigandPNGBDBM310195(US9603836, Compound 2 | (-)-(R)-3-(5-fluoro-1H- in...)
Affinity DataIC50: 120nMAssay Description:Inhibition of human recombinant IDO-1 using L-Trp as substrate after 15 mins by PDMAB-based assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2020
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetIndoleamine 2,3-dioxygenase 1(Human)
Iteos Therapeutics

Curated by ChEMBL
LigandPNGBDBM310195(US9603836, Compound 2 | (-)-(R)-3-(5-fluoro-1H- in...)
Affinity DataIC50: 200nMAssay Description:To measure enzymatic activity of human IDO1, the reaction mixture contained (final concentrations) potassium phosphate buffer (50 mM, pH 6.5), ascorb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2021
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetIndoleamine 2,3-dioxygenase 1(Human)
Iteos Therapeutics

Curated by ChEMBL
LigandPNGBDBM310195(US9603836, Compound 2 | (-)-(R)-3-(5-fluoro-1H- in...)
Affinity DataIC50: 200nMAssay Description:Inhibition of human recombinant IDO-1 using tryptophan as substrate after 22 mins by LC-MS/MS methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2020
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetIndoleamine 2,3-dioxygenase 1(Human)
Iteos Therapeutics

Curated by ChEMBL
LigandPNGBDBM310195(US9603836, Compound 2 | (-)-(R)-3-(5-fluoro-1H- in...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of IDO-1 in IFN-gamma-stimulated human HeLa cells assessed as decrease in kynurenine production after 16 to 24 hrs by PDMAB methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2020
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetIndoleamine 2,3-dioxygenase 1(Human)
Iteos Therapeutics

Curated by ChEMBL
LigandPNGBDBM310195(US9603836, Compound 2 | (-)-(R)-3-(5-fluoro-1H- in...)
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of IDO-1 in IFN-gamma/LPS-stimulated human THP1 cells assessed as decrease in kynurenine production after 16 to 24 hrs by PDMAB methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2020
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetIndoleamine 2,3-dioxygenase 1(Human)
Iteos Therapeutics

Curated by ChEMBL
LigandPNGBDBM310195(US9603836, Compound 2 | (-)-(R)-3-(5-fluoro-1H- in...)
Affinity DataIC50: 2.50E+3nMAssay Description:Inhibition of IDO-1 in IFN-gamma/LPS-stimulated human whole blood assessed as decrease in kynurenine production after 24 hrs by LC-MS/MS methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2020
Entry Details Article
PubMedPDB3D3D Structure (crystal)